Gimv's risk reduction

Gimvmaintains that biotech companies need not worry that the firm's new Health & Care Fund includes only two of the VC's three pillar investment areas in that sector - medtech and healthcare services - but not life sciences.

According to spokesperson Frank De Leenheer, Gimv makes almost all of its biotech investments from its Euronext-listed vehicle and hasn't lost any interest in the life sciences space...